Skip to main content
. 2013 May 28;8(5):e65513. doi: 10.1371/journal.pone.0065513

Figure 2. Epigenetic changes at the PRSS8 locus in UROtsa cells chronically treated with CSE.

Figure 2

Percentage of methylation at 9 CpG sites in the PRSS8 promoter determined by bisulfite sequencing of genomic DNA extracted from UROtsa cells chronically treated with CSE, UROCSE-p32 (32nd passage) and from untreated cells, UROtsa-p32 (32nd passage). Percentage of methylation was calculated by the number of methylated cytosines at each CpG site observed in the total number of independent clones sequenced for each BS DNA amplicon, n = 60 for both UROtsa-p32 and UROCSE-p32.